For decades, the gut has been recognized primarily as the site of nutrient absorption, with limited understanding of its direct role in glucose handling beyond uptake. However, the current study challenges this notion by demonstrating that the intestine can actively excrete glucose under pathological conditions such as diabetes mellitus. Central to this phenomenon is the atypical protein kinase C, a member of the protein kinase C family, which operates through unique regulatory pathways distinct from classical and novel PKCs, governing diverse cellular processes including signal transduction and metabolism.

The research team employed a multifaceted approach combining advanced molecular biology techniques, genetically engineered animal models, and human clinical data to elucidate the mechanism by which aPKC activation induces glucose excretion in the intestine. Using transgenic mice with intestine-specific upregulation of aPKC, the scientists observed a significant increase in glucose efflux into the intestinal lumen, effectively lowering systemic blood glucose levels despite concurrent hyperglycemia. This discovery suggests an adaptive, albeit maladaptive in chronic states, compensatory pathway activated in diabetes.

Further biochemical analyses revealed that aPKC activation modulates the function and expression of key glucose transporters, notably the sodium-glucose co-transporter 1 (SGLT1) and glucose transporter 2 (GLUT2), shifting their activities to favor glucose secretion rather than absorption. This switch in transporter dynamics occurs via phosphorylation events triggered by aPKC, altering their localization and transport kinetics. These findings provide the first evidence that glucose transporters are not unidirectional conduits but can be regulated to operate in reverse under certain pathological stimuli.

Delving deeper, the team identified upstream signals responsible for stimulating aPKC activation, including elevated free fatty acids and inflammatory cytokines characteristic of the diabetic milieu. These factors converge on intracellular signaling cascades that culminate in aPKC phosphorylation and activation. Once activated, aPKC initiates a feedback mechanism that influences gut epithelial cell metabolism and barrier functions, linking metabolic dysregulation with mucosal homeostasis.

Importantly, the researchers uncovered that this aPKC-driven pathway contributes to a significant loss of calories through intestinal glucose excretion, which may partly explain the paradoxical weight loss seen in some individuals with poorly controlled diabetes. However, this glucose loss is not sufficient to normalize blood sugar levels, underlining the complexity of glucose homeostasis in diabetic patients. This insight opens avenues for designing drugs that could selectively enhance intestinal glucose clearance without adverse consequences.

The clinical implications of these findings are immense, as they reveal a previously unrecognized target for diabetes management. Therapeutic strategies aimed at modulating aPKC activity in the gut could provide a complementary approach to existing treatments, potentially improving glycemic control by promoting intestinal glucose clearance. Moreover, understanding this pathway might help mitigate complications related to chronic hyperglycemia and metabolic syndrome by addressing aberrant glucose handling at the intestinal interface.

From a translational perspective, the team is already exploring small molecule inhibitors and activators of aPKC, carefully characterizing their efficacy and safety profiles in preclinical models. Early results suggest that fine-tuning aPKC activity can favorably adjust glucose excretion rates without compromising intestinal integrity or systemic metabolism. These promising developments hint at a new class of therapeutics that could transform the management of diabetes mellitus.

The study also emphasizes the importance of the gut as a critical organ in systemic metabolic regulation, complementing the roles traditionally attributed to the pancreas, liver, and muscle tissues. It aligns with emerging research highlighting the gut’s active participation in metabolic homeostasis and provides a molecular framework supporting gut-targeted interventions in metabolic diseases.

To facilitate future research, the authors have made their raw data and genetically modified mouse models available to the scientific community, encouraging collaborative efforts to dissect the broader implications of aPKC in gastrointestinal and systemic metabolism. The cross-disciplinary nature of this work bridges endocrinology, gastroenterology, and molecular biology, fostering a comprehensive understanding of metabolic diseases.

In conclusion, the identification of atypical protein kinase C as a driver of intestinal glucose excretion marks a paradigm shift in diabetes research. It uncovers a hidden facet of gut physiology with direct implications for disease pathogenesis and treatment. As the global burden of diabetes continues to rise, discoveries like this illuminate new paths to better patient outcomes and novel therapeutic horizons, heralding a new era in metabolic medicine.

Subject of Research:
Role of atypical protein kinase C in regulating intestinal glucose excretion in diabetes mellitus.

Article Title:
Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus.

Article References:
Kang, C.W., Hong, ZY., Oh, J.H. et al. Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus. Nat Commun (2026). https://doi.org/10.1038/s41467-026-69193-7

Image Credits:
AI Generated

This novel research aimed to unravel the intricate link between ultra-processed food intake and glucose homeostasis, a critical physiological process underpinning diabetes risk. By assessing changes in dietary patterns alongside metabolic markers over a substantial four-year span, the investigators provided compelling evidence that even moderate increases in UPF consumption compromise the body’s ability to regulate blood sugar effectively. Such dysregulation is an early harbinger of prediabetes, a condition characterized by elevated blood glucose levels that precedes type 2 diabetes.

The study cohort comprised 85 young adults aged between 17 and 22 years, all with a history of overweight or obesity—a population segment uniquely vulnerable to metabolic disturbances. Baseline dietary assessments were conducted between 2014 and 2018, with follow-up evaluations approximately four years later. Food consumption was meticulously recorded for representative weekday and weekend days, with participants self-reporting all intake during these periods. Foods were then systematically categorized into ultra-processed and non-ultra-processed groups based on established definitions, with UPFs encompassing items such as sweets, sodas, breakfast cereals with additives, flavoured yogurts, and various meals sourced from restaurants.

Crucially, metabolic assessments involved oral glucose tolerance testing (OGTT), wherein participants ingested a standardized sugary beverage, and subsequent blood samples were collected to evaluate the body’s insulin response. The researchers analyzed changes in insulin secretion and glucose levels, allowing for a granular understanding of how dietary changes impacted glucose homeostasis. Statistical adjustment accounted for confounders such as age, sex, ethnicity, and physical activity levels to isolate the effect of UPF consumption.

Results revealed a stark association: a mere 10% increment in the proportion of calories derived from ultra-processed foods correlated with a 64% increase in the risk of developing prediabetes and a 56% heightened prevalence of impaired glucose regulation. Participants exhibiting higher UPF consumption at the study’s inception exhibited increased fasting insulin levels during follow-up, indicating the development of insulin resistance. Insulin resistance denotes a pathological state wherein target tissues become refractory to insulin, prompting compensatory hyperinsulinemia and progressively deteriorating glycemic control.

These findings bear profound implications, particularly given that young adulthood represents a critical window for establishing enduring health trajectories. Whereas much prior research has concentrated on middle-aged or older adults, this study spotlights the metabolic vulnerabilities intrinsic to late adolescence and early adulthood. Dr. Vaia Lida Chatzi, senior author and professor of population and public health sciences and pediatrics at USC’s Keck School of Medicine, emphasized the modifiability of diet during this life stage, highlighting the potential for early intervention to forestall the progression of metabolic diseases.

The research underscores the necessity of dietary shifts away from ultra-processed consumption towards whole, minimally processed foods rich in fruits, vegetables, and whole grains. Such nutritional realignments are anticipated to enhance insulin sensitivity and stabilize glucose levels, mitigating long-term diabetes risk. This transition is particularly salient in populations predisposed to obesity, where metabolic dysregulation is already underway. The study’s longitudinal design strengthens causal inferences, shedding light on temporal dynamics between dietary choices and physiological outcomes.

Beyond epidemiological associations, the study team advocates for mechanistic investigations to unravel how specific components of ultra-processed foods influence metabolic pathways. Additives, emulsifiers, flavor enhancers, and macronutrient imbalances characteristic of UPFs may disrupt gut microbiota, promote systemic inflammation, or alter insulin signaling cascades. Such insights could pave the way for targeted nutritional recommendations and regulatory policies to curb the pervasive consumption of metabolically harmful foods.

Lead author Yiping Li, a doctoral candidate in quantitative biomedical sciences at Dartmouth College, reflected on the importance of expanding research cohorts and refining dietary measurement methodologies. Deploying objective biomarkers and high-resolution diet tracking would allow disaggregation of UPFs by subtype, illuminating which food categories pose the greatest hazards to young adults’ metabolic health.

This investigation was conducted in the context of the broader Metabolic and Asthma Incidence Research (Meta-AIR) study, nested within the Southern California Children’s Health Study, which tracks environmental and biological factors influencing pediatric and adolescent health. The research was supported by multiple grants from the National Institute of Environmental Health Sciences (NIEHS), the U.S. Environmental Protection Agency, the European Union, and other funding bodies, reflecting its multidisciplinary and international relevance.

Collectively, this study crystallizes the escalating public health challenge posed by ultra-processed foods, spotlighting critical vulnerabilities during the transition to adulthood. In the face of a global rise in type 2 diabetes incidence among youth, these findings amplify calls for comprehensive dietary interventions, public education campaigns, and policy measures designed to reduce UPF availability and consumption. Addressing the metabolic consequences of food processing transcends simple nutritional debates, intersecting with broader socioeconomic, cultural, and regulatory dimensions of health promotion.

By focusing on the young adult demographic, researchers and healthcare professionals gain a strategic vantage point to implement early preventive strategies, potentially averting lifelong metabolic dysfunction. This emerging evidence base supports a paradigm wherein nutritional quality, food processing degree, and metabolic health are inseparably linked—an insight that may redefine counseling, clinical practice, and public health initiatives in the coming decades.

Subject of Research: Ultra-processed food consumption and its longitudinal effects on glucose regulation and prediabetes risk in young adults with a history of overweight or obesity.

Article Title: Ultra-processed food intake is associated with altered glucose homeostasis in young adults with a history of overweight or obesity: a longitudinal study.

News Publication Date: November 10, 2025.

Web References: Nutrition and Metabolism Journal Article, DOI: 10.1186/s12986-025-01036-6.

Keywords: Metabolic disorders, diabetes, obesity, dietetics, diets, age groups, adolescents, young people, insulin resistance, insulin.